Articles liés à Proteomic Strategy for Cancer Biomarker Discovery:...
Proteomic Strategy for Cancer Biomarker Discovery: Focus on Cancer Specific Proteins for Diagnostic Purposes - Couverture souple
Synopsis
Worldwide over 25 million people have cancer and more than 10 million die from it each year. There is a growing focus on cancer diagnosis because accurate and timely detection of the disease means a better chance for patient survival and lower treatment costs. Today’s diagnostic screening methods are often inadequate due to their low accuracy. So far, the high complexity of blood prohibited the sensitive and high throughput profiling of patient sample sets large enough to reliably detect cancer-indicating differences. Yet despite intensive interest and investment, only a few cancer biomarkers are used in clinical practice. This book will give you an overview of the establishment of a new strategy for the discovery, verification and validation of cancer protein biomarkers. Thereby different technological and biological aspects are discussed. Finally, the preliminary results of a prostate cancer study, which resulted in the identification of a panel of new protein biomarker superior to the current standard PSA (prostate specific antigen), are shown.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
À propos de l?auteur
Ralph Schiess, Dr. sc. ETH: Studies in biochemistry at theInstitute of Molecular Systems Biology, ETH Zurich with a focus on mass spectrometrybased proteomics and protein biomarker research, Ph.D. received 2008.
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
Acheter neuf
Afficher cet article
EUR 3,95
EUR 10,34 expédition depuis Allemagne vers France
Destinations, frais et délaisRésultats de recherche pour Proteomic Strategy for Cancer Biomarker Discovery:...
Image fournie par le vendeur
Proteomic Strategy for Cancer Biomarker Discovery: Focus on Cancer Specific Proteins for Diagnostic Purposes
Edité par
Südwestdeutscher Verlag Für Hochschulschriften, 2009
ISBN 10 : 3838106393
ISBN 13 : 9783838106397
Neuf
Taschenbuch
Vendeur : Che & Chandler Versandbuchhandlung, Fürstenberg OT Blumenow, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Taschenbuch. Etat : Neu. Neu Neuware; original eingeschweisst; Rechnung mit MwSt.; new item, still sealed; -Worldwide over 25 million people have cancer and more than 10 million die from it each year. There is a growing focus on cancer diagnosis because accurate and timely detection of the disease means a better chance for patient survival and lower treatment costs. Today's diagnostic screening methods are often inadequate due to their low accuracy. So far, the high complexity of blood prohibited the sensitive and high throughput profiling of patient sample sets large enough to reliably detect cancer-indicating differences. Yet despite intensive interest and investment, only a few cancer biomarkers are used in clinical practice. This book will give you an overview of the establishment of a new strategy for the discovery, verification and validation of cancer protein biomarkers. Thereby different technological and biological aspects are discussed. Finally, the preliminary results of a prostate cancer study, which resulted in the identification of a panel of new protein biomarker superior to the current standard PSA (prostate specific antigen), are shown. 164 pp. Deutsch. N° de réf. du vendeur INF1100262105
Quantité disponible : 2 disponible(s)
Image fournie par le vendeur
Proteomic Strategy for Cancer Biomarker Discovery: Focus on Cancer Specific Proteins for Diagnostic Purposes
Edité par
Südwestdeutscher Verlag Für Hochschulschriften, 2009
ISBN 10 : 3838106393
ISBN 13 : 9783838106397
Neuf
Taschenbuch
Vendeur : Versandbuchhandlung Kisch & Co., Fürstenberg OT Blumenow, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Taschenbuch. Etat : Neu. Neu Neuware; original eingeschweisst; Rechnung mit MwSt.; new item, still sealed; -Worldwide over 25 million people have cancer and more than 10 million die from it each year. There is a growing focus on cancer diagnosis because accurate and timely detection of the disease means a better chance for patient survival and lower treatment costs. Today's diagnostic screening methods are often inadequate due to their low accuracy. So far, the high complexity of blood prohibited the sensitive and high throughput profiling of patient sample sets large enough to reliably detect cancer-indicating differences. Yet despite intensive interest and investment, only a few cancer biomarkers are used in clinical practice. This book will give you an overview of the establishment of a new strategy for the discovery, verification and validation of cancer protein biomarkers. Thereby different technological and biological aspects are discussed. Finally, the preliminary results of a prostate cancer study, which resulted in the identification of a panel of new protein biomarker superior to the current standard PSA (prostate specific antigen), are shown. 164 pp. Deutsch. N° de réf. du vendeur INF1100262105
Quantité disponible : 2 disponible(s)
Image fournie par le vendeur
Proteomic Strategy for Cancer Biomarker Discovery
Edité par
Südwestdeutscher Verlag für Hochschulschriften, 2015
ISBN 10 : 3838106393
ISBN 13 : 9783838106397
Neuf
Couverture souple
Vendeur : moluna, Greven, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Worldwide over 25 million people have cancer and more than 10 million die from it each year. There is a growing focus on cancer diagnosis because accurate and timely detection of the disease means a better chance for patient survival and lower treatment cos. N° de réf. du vendeur 5405026
Quantité disponible : Plus de 20 disponibles
Image fournie par le vendeur
Proteomic Strategy for Cancer Biomarker Discovery : Focus on Cancer Specific Proteins for Diagnostic Purposes
Edité par
Südwestdeutscher Verlag Für Hochschulschriften AG Co. KG, 2009
ISBN 10 : 3838106393
ISBN 13 : 9783838106397
Neuf
Taschenbuch
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Worldwide over 25 million people have cancer and more than 10 million die from it each year. There is a growing focus on cancer diagnosis because accurate and timely detection of the disease means a better chance for patient survival and lower treatment costs. Today's diagnostic screening methods are often inadequate due to their low accuracy. So far, the high complexity of blood prohibited the sensitive and high throughput profiling of patient sample sets large enough to reliably detect cancer-indicating differences. Yet despite intensive interest and investment, only a few cancer biomarkers are used in clinical practice. This book will give you an overview of the establishment of a new strategy for the discovery, verification and validation of cancer protein biomarkers. Thereby different technological and biological aspects are discussed. Finally, the preliminary results of a prostate cancer study, which resulted in the identification of a panel of new protein biomarker superior to the current standard PSA (prostate specific antigen), are shown. N° de réf. du vendeur 9783838106397
Quantité disponible : 1 disponible(s)
Image fournie par le vendeur
Proteomic Strategy for Cancer Biomarker Discovery
ISBN 10 : 3838106393
ISBN 13 : 9783838106397
Neuf
Taschenbuch
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Worldwide over 25 million people have cancer and more than 10 million die from it each year. There is a growing focus on cancer diagnosis because accurate and timely detection of the disease means a better chance for patient survival and lower treatment costs. Today's diagnostic screening methods are often inadequate due to their low accuracy. So far, the high complexity of blood prohibited the sensitive and high throughput profiling of patient sample sets large enough to reliably detect cancer-indicating differences. Yet despite intensive interest and investment, only a few cancer biomarkers are used in clinical practice. This book will give you an overview of the establishment of a new strategy for the discovery, verification and validation of cancer protein biomarkers. Thereby different technological and biological aspects are discussed. Finally, the preliminary results of a prostate cancer study, which resulted in the identification of a panel of new protein biomarker superior to the current standard PSA (prostate specific antigen), are shown. 164 pp. Deutsch. N° de réf. du vendeur 9783838106397
Quantité disponible : 2 disponible(s)
Image fournie par le vendeur
Proteomic Strategy for Cancer Biomarker Discovery
ISBN 10 : 3838106393
ISBN 13 : 9783838106397
Neuf
Taschenbuch
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Taschenbuch. Etat : Neu. Neuware -Worldwide over 25 million people have cancer and more than 10 million die from it each year. There is a growing focus on cancer diagnosis because accurate and timely detection of the disease means a better chance for patient survival and lower treatment costs. Today¿s diagnostic screening methods are often inadequate due to their low accuracy. So far, the high complexity of blood prohibited the sensitive and high throughput profiling of patient sample sets large enough to reliably detect cancer-indicating differences. Yet despite intensive interest and investment, only a few cancer biomarkers are used in clinical practice. This book will give you an overview of the establishment of a new strategy for the discovery, verification and validation of cancer protein biomarkers. Thereby different technological and biological aspects are discussed. Finally, the preliminary results of a prostate cancer study, which resulted in the identification of a panel of new protein biomarker superior to the current standard PSA (prostate specific antigen), are shown.Books on Demand GmbH, Überseering 33, 22297 Hamburg 164 pp. Deutsch. N° de réf. du vendeur 9783838106397
Quantité disponible : 2 disponible(s)
Image fournie par le vendeur
Proteomic Strategy for Cancer Biomarker Discovery | Focus on Cancer Specific Proteins for Diagnostic Purposes
Edité par
Südwestdeutscher Verlag für Hochschulschriften AG Co. KG, 2015
ISBN 10 : 3838106393
ISBN 13 : 9783838106397
Neuf
Taschenbuch
Vendeur : preigu, Osnabrück, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Taschenbuch. Etat : Neu. Proteomic Strategy for Cancer Biomarker Discovery | Focus on Cancer Specific Proteins for Diagnostic Purposes | Ralph Schiess | Taschenbuch | 164 S. | Deutsch | 2015 | Südwestdeutscher Verlag für Hochschulschriften AG Co. KG | EAN 9783838106397 | Verantwortliche Person für die EU: BoD - Books on Demand, In de Tarpen 42, 22848 Norderstedt, info[at]bod[dot]de | Anbieter: preigu. N° de réf. du vendeur 101562589
Quantité disponible : 5 disponible(s)
Image d'archives
Proteomic Strategy for Cancer Biomarker Discovery (German Edition)
Edité par
S dwestdeutscher Verlag f r Hochschulschriften, 2009
ISBN 10 : 3838106393
ISBN 13 : 9783838106397
Neuf
paperback
Vendeur : Mispah books, Redhill, SURRE, Royaume-Uni
Évaluation du vendeur 4 sur 5 étoiles
paperback. Etat : New. New. book. N° de réf. du vendeur ERICA82938381063935
Quantité disponible : 1 disponible(s)